Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 7
- 0 vs. Q3 2025
- Portfolio value
- $506.8M
- +$179.3M (+54.7%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZBIOZenas BioPharma, Inc. | COM | 3,919,159 | $142.3M | 28.1% | +157,800+4.2% | Added | History |
| IMNMImmunome Inc. | COM | 4,768,583 | $102.4M | 20.2% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $101.9M | 20.1% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $66.8M | 13.2% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $41.8M | 8.3% | 00.0% | Unchanged | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 2,626,946 | $32.9M | 6.5% | 00.0% | Unchanged | History |
| CAMPCamp4 Therapeutics Corp | COM | 3,035,825 | $18.6M | 3.7% | −749,977−19.8% | Reduced | History |